Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience

BACKGROUND: The subcutaneous implantable cardioverter defibrillator (S‐ICD) has been developed to avert risks associated with transvenous defibrillator leads. The technology is attractive for younger patients, such as those with hypertrophic cardiomyopathy (HCM). However, there are limited data on S...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinstock, Jonathan, Bader, Yousef H., Maron, Martin S., Rowin, Ethan J., Link, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802466/
https://www.ncbi.nlm.nih.gov/pubmed/26873684
http://dx.doi.org/10.1161/JAHA.115.002488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802466/
https://www.ncbi.nlm.nih.gov/pubmed/26873684
http://dx.doi.org/10.1161/JAHA.115.002488

Ejemplares similares